Microcirculation and tissue metabolism in peripheral arterial disease

Clinical Hemorheology and Microcirculation

Volumn 21, Issue 3-4, 1999, Pages 245-254

  Brevetti, Gregorio ^a,b   Corrado, Salvatore ^a   Martone, Vincenzo Domenico ^a   Di Donato, AnnaMaria ^a   Silvestro, Antonio ^a   Vanni, Luigi ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CARNITINE; NITRIC OXIDE; VERAPAMIL;

ARTERY DISEASE; ATHEROSCLEROSIS; CONFERENCE PAPER; DISEASE SEVERITY; GLUCOSE OXIDATION; INTERMITTENT CLAUDICATION; MICROCIRCULATION; MUSCLE ISCHEMIA; OXYGEN TRANSPORT; TISSUE METABOLISM; TISSUE OXYGENATION;

ANIMALS; HUMANS; INTERMITTENT CLAUDICATION; MICROCIRCULATION; MUSCLE, SKELETAL; PERIPHERAL VASCULAR DISEASES;

EID: 0033494279     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (52)

1. W.B. Kannell and D.L. Mc Gee, Update on some epidemiologic features of intermittent claudication: the Framingham study, J. Am. Geriatr. Soc. 33 (1985), 13-18.
2. M.D. Mc Daniel and J.L. Cronewett, Basic data related to the natural history of intermittent claudication, Ann. Vasc. Surg. 3 (1989), 273-277.
3. B. Arfiderson, J. Karlson, A.G. Dahllof, K. Lundhorm and M. Sullivan, The impact of intermittent claudication on quality of life evaluated by the Sickness Impact Profile Technique, Eur. J. Clin. Invest. 23 (1993), 741-745.
4. G. Barletta, S. Perna, C. Sabbà, A. Catalano, C. O'Boyle and G. Brevetti, Quality of life in patients with intermittent claudication: relationship with laboratory exercise performance, Vascular Medicine 1 (1996), 3-7.
5. 15O positron emission tomography study, Clin. Sci. 93 (1997), 159-165.
6. W.R. Hiatt, E.E. Wolfel, J.G. Regensteiner and E.P. Brass, Skeletal muscle camitine metabolism in patients with unilateral peripheral arterial disease, J. Appl. Physiol. 73(3) (1992), 346-353.
7. 31P magnetic resonance spectroscopy, Clin. Sci. 89 (1995), 581-590.
8. B. Pernow, B. Saltin, J. Wahren, R. Cronestrand and S. Ekestrom, Leg blood flow and muscle metabolism in occlusive arterial disease of the leg before and after reconstructive surgery, Clin. Sci. 49 (1975), 265-275.
9. G. Brevetti, M. Chiariello, F. Rengo, G. Lavecchia, G. Paudice and M. Condorelli, Protective effect of propanolol on the exercise-induced reduction of blood flow in arteriopathic patients, Angiology 30(10) (1979), 696-702.
10. A.T. Edwards, A.D. Blann, V.J. Suarez-Mendez, A.M. Lardi and C.N. Mc Collum, Systemic responses in patients with intermittent claudication after treadmill exercise, Br. J. Surgery 81 (1994), 1738-1741.
11. N.C. Hichey, O. Hudlicka, P. Gosling, C.P. Sherman and M.H. Simms, Intermittent claudication incites systemic neutrophil activation and increased vascular permeability, Br. J. Surgery 80 (1993), 181-184.
12. I.A. Thompson, S. Egginton, M.H. Simms and O. Hudlicka, Effect of muscle ischaemia and iloprost during femorodistal reconstruction on capillary endothelial swelling. Int. J. Microcirc. Clin. Exp. 16(6) (1996), 284-290.
13. S.M. Albelda, C. Wayne Smith and P.A. Ward, Adhesion molecules and inflammatory injury, FASEB J. 8 (1994), 504-512.
14. Ad. Blann and C.N. Mc Collum, Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis, Thromb. Haemost. 72 (1994), 151-154.
15. G. Brevetti, M. De Caterina, B. Ungaro, V.D. Martone, A.M. Di Donato and F. Scopacasa, Increased soluble form of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 in intermittent claudication, JACC 31 (1998), 498 A.
16. R.H. Boger, S.M. Bode-Boger, W. Thiele, W. Junker, K. Alexander and J.C. Frolich, Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial disease, Circulation 95 (1997), 2068-2074.
17. F.J. Neumann, W. Waas, C. Diehm, T. Weiss, H.M. Haupt, R. Zimmermann, H. Tillmanns and W. Kübler, Activation and decreased deformability of neutrophils after intermittent claudication, Circulation 82 (1990), 922-929.
18. P. Gresele, M. Catalano, C. Giammaresi, R. Volpato, R. Termini, G. Ciabattoni, G.G. Nenci and G. Davì, Platelet activation markers in patients with peripheral arterial disease, Thromb. Haemost. 78 (1997), 1434-1437.
19. G.B. Nash and C.P. Shearman, Neutrophils and peripheral arterial disease (part 1), Critical Ischamia 2 (1992), 5-13.
20. G. Ciuffetti, M. Mercuri, R. Lombardini, G. Maragoni, L. Santabrogio and E. Mariarino, Leucocyte behaviour in controlled ischaemia of the calves, J. Clin. Pathol. 42 (1989), 1083-1087.
21. G. Ciuffetti, R. Lombardini, R. Paltriccia, L. Santambrogio and E. Mannarino, Human leukocyte-endothelial interactions in peripheral arterial occlusive disease, Eur. J. Clin. Invest. 24 (1994), 65-68.
22. N.C. Hickey, P. Gosling, S. Baar, C.P. Shearman and M.H. Simms, Effect of surgery on the systemic inflammatory response to intermittent claudication, Br. J. Surg. 77 (1990), 1121-1124.
23. H.L. Reid, A.J. Barnes, P.J. Lock, J.A. Dormandy and T.L. Dormandy, A simple method for measuring erythrocyte deformability, J. Clin. Path. 29 (1976), 855-890.
24. B.R. Duling and R.M. Berne, Longitudinal gradients in periarteriolar oxygen tension. A possible mechanism for the participation of oxygen in the local regulation of blood flow, Circ. Res. 27 (1970), 669-678.
25. M. Intaglietta, P.C. Johnson and R.M. Winslow, Microvascular and tissue oxygen distribution, Cardiovasc. Res. 32 (1996), 632-643.
26. S.E. Curtis, B. Vallet, M.J. Winn, J.B. Caufield, C.E. King, C.K. Chapler and S.M. Cain, Role of vascular endothelium in O2 extraction during progressive ischemia in canine skeletal muscle, J. Appl. Physiol. 79(4) (1995), 1351-1360.
27. S.P. Bruttig and W.L. Joyner, Metabolic characteristics of cells cultured from umbilical blood vessels: comparison with 3T3 fibroblasts, J. Cell Physiol. 116 (1983), 173-180.
28. C.A. Boswell, G. Majno, I. Joris and K.A. Ostrom, Acute endothelial cell concentration in vitro: a comparison with vascular smooth muscle cells and fibroblasts, Microvasc. Res. 43 (1992), 178-191.
29. N.L. Jones, G.J. Heigenhauser, A. Kuksis, C.G. Matsos, J.R. Sutton and C.J. Toews, Fat metabolism in heavy exercise, Clin. Sci. Lond. 59 (1980), 469-478.
30. F. Pirnay, Crielaard, N. Pallikarakis, M. Lacroix, F. Mosora, G. Krzentowski, A.S. Luyckx and P.J. Lefebvre, Fate of exogenous glucose during exercise of different intensities in humans, J. Appl. Physiol. 53 (1982), 1620-1624.
31. P. Cerretelli and C. Marconi, L-camitine supplementation in humans. The effects on physical performance, Int. J. Sports Med. 11 (1990), 1-14.
32. W.R. Hiatt, J.G. Regensteiner, E.E. Wolfel, L. Ruff and E.P. Brass, Carnitine and acylcarnitine metabolism during exercise in humans: dependence on skeletal muscle metabolic state, J. Clin. Invest. 84 (1989), 1167-1173.
33. 31P magnetic resonance spectroscopy, Clin. Sci. 89 (1995), 581-590.
34. W.R. Hiatt, D. Nawaz and E.P. Brass, Carnitine metabolism during exercise in patients with peripheral vascular disease, J. Appl. Physiol. 62(6) (1987), 2383-2387.
35. W.R. Hiatt, E.E. Wolfel, J.G. Regensteiner and E.P. Brass, Skeletal muscle carnitine metabolism in patients with unilateral peripheral arterial disease, J. Appl. Physiol. 73(1) (1992), 346-353.
36. G. Brevetti, F. Di Lisa, S. Perna, R. Menabò, R. Barbato, V.D. Martone and N. Siliprandi, Carnitine-related alterations in patients with intermittent claudication. Indication for a focused carnitine therapy, Circulation 93 (1996), 1685-1689.
37. G. Brevetti, M. Chiariello, G. Ferulano, A. Policicchio, E. Nevola, T. Attisano, G. Ambrosio, N. Siliprandi and C. Angelini, Increases in walking distance in patients with peripheral vascular disease treated with L-carnitine: a double-blind, cross-over study, Circulation 77 (1988), 767-773.
38. H.A. Cameron, P.C. Waller and L.E. Ramsay, Drug treatment of intermittent claudication: a critical analysis of the methods and findings of the published clinical trials, 1965-1985, Br. J. Clin. Pharmac. 26 (1988), 569-576.
39. K. Radack and R.J. Wyderski, Conservative management of intermittent claudication, Ann. Int. Med. 113 (1990), 135-146.
40. 15O positron emission tomography study, Clin. Sci. 93 (1997), 159-165.
41. R.H. Boger, S.M. Bode-boger, W. Thiele, A. Creutzig, K. Alexander and J.C. Frolich, Restoring vascualr nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease, JACC 32(5) (1998), 1336-1344.
42. J.P. Cooke and P.S. Tsao, Arginine: a new therapy for atherosclerosis?, Circulation 95 (1997), 311-312.
43. R. Ekroth, A.G. Dahllof, B. Gundevall, J. Holm and T. Shersten, Physical training of patients with intermittent claudication: indications, methods and results, Surgery 84 (1978), 640-643.
44. W.R. Hiatt, J.G. Regensteiner, M.E. Hargarten, E.E. Wolfel and E.P. Brass, Benefit of exercise conditioning for patients with peripheral arterial disease, Circulation 81 (1990), 602-609.
45. J.P. Bagger, R. Mathar, P.K. Paulsen, J. Gormsen and K.H. Olsen, Verapamil induced increment of oxygen in the arte-riosclerotic limb, Cardiovasc. Res. 19 (1985), 567-569.
46. J.P. Bagger, P. Helligsoe, F. Randsbaek, H.H. Kimose and B.S. Jensen, Effect of verapamil in intermittent claudication. A randomized, double-blind, placebo-controlled, cross-over study after individual dose-response assessment, Circulation 95 (1997), 411-414.
47. G. Brevetti, C. Angelini, M. Rosa, R. Carrozzo, S. Perna, M. Corsi, A. Matarazzo and A, Marcialis, Muscle carnitine deficiency in patients with severe peripheral vascular disease, Circulation 84 (1991), 1490-1495.
48. G. Brevetti, M. Fanin, V. De Amicis, R. Carrozzo, F. Di Lello, V.D. Martone and C. Angelini, Changes in skeletal muscle histology and metabolism in patients undergoing exercise deconditioning: effect of propionyl-L-carnitine, Muscle Nerve 20 (1997), 1115-1120.
49. V. Tassani, F. Cattapan, L. Magnanimi and A. Peschechera, Anapierotic effect of propionyl camitine in rat heart mitochondria, Biochem. Biophys. Res. Comm. 199 (1994), 949-953.
50. G. Brevetti, S. Perna, C. Sabbà, A. Rossini, V. Scotto di Uccio, E. Berardi and L. Godi, Superiority of L-propionylcarnitine vs L-carnitine in improving walking capacity in patients with peripheral vascular disease: an acute, intravenous, doubleblind, cross-over study, Eur. Heart J. 13 (1992), 251-256.
51. G. Brevetti, S. Perna, C. Sabbà, V.D. Martone and M. Condorelli, Propionyl-L-carnitine in intermittent claudication: double-blind, placebo-controlled, dose titration, multicenter study, JACC 26 (1995), 1411-1416.
52. G. Brevetti, S. Perna, C. Sabba, V.D. Martone, A. Di Iorio and G. Barletta, Effect of propionyl-L-carnitine on quality of life in intermittent claudication, Am. J. Cardiol. 79 (1997), 777-785.